Health and Medicine

A monoclonal antibody developed by researchers at the University at Buffalo has been shown to extend significantly the survival of mice with human breast-cancer tumors and to inhibit the cancer's spread to the lungs in the animals by more than 50 percent.

The National Institute on Alcohol Abuse and Alcoholism has awarded a $579,325 grant to Amy Hequembourg, Ph.D., of the University at Buffalo's Research Institute on Addictions to study the role of gender and sexual identity in alcohol use and victimization.

Research by endocrinologists at the University at Buffalo has shown that one-third of men with type 2 diabetes who have low testosterone concentrations are likely to have anemia, due to two mechanisms that suppress the formation of red blood cells.

A study by psychologists at the University at Buffalo and the University of California, Irvine, has found that people's gender and ethnicity predicted their immediate response to the 9/11 terrorist attacks and their general state of health over the next two years.

Understanding of the transition into adolescence and what may promote or mitigate substance abuse in adolescents will be advanced by research conducted by a University at Buffalo psychologist that is being funded by two grants totaling more than $4.1 million from the National Institute on Drug Abuse (NIDA).

A reproductive medicine specialist at the University at Buffalo has shown that a new compound may improve the fertility of tobacco smokers who have low sperm count and low percentage sperm motility.

Jean K. Brown., Ph.D., professor and associate dean of the University at Buffalo School of Nursing, was named interim dean of the nursing school Nov. 14 following the resignation due to illness of Mecca S. Cranley, Ph.D.

Mecca S. Cranley, Ph.D., dean of the University at Buffalo School of Nursing since 1991, died Nov. 20 in the hospice unit at Sister's Hospital in Buffalo, surrounded by her family. The cause was multiple myeloma, cancer of the bone marrow. She was 67.

The University at Buffalo team that developed the world's first transgenic butterfly now has developed an innovative tool that will allow scientists studying "non-model" organisms to test directly the function of certain genes, even in the absence of genome sequencing information.

In their continuing search for promising targets for treating mental disorders, a group of neuroscientists at the University at Buffalo has identified a pathway critical to the functioning of antidepressants, antipsychotic drugs and drugs for anxiety disorders.